Inadequate Initial Response is the Top Reason Why Rheumatologists Move Patients from Simponi and Cimzia, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 7, 2010 /PRNewswire/ ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that there has been a slight increase in ...

Humira Leads Remicade in the Treatment Algorithm for Psoriatic Arthritis Despite Launching Around the Same Time, According to New Analysis from Decision Resources BURLINGTON, Mass.--(BUSINESS WIRE)-- ...

Every time Charlotte publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Please provide your email address to receive an email when new articles are posted on . On May 11, Icelandic-based drug developer Alvotech filed a lawsuit against AbbVie seeking to undo what it ...

Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar versions as part of its Biosimilars Initiative. Alberta, Canada has expanded ...

Biologic drugs that treat various autoimmune disorders have seen substantial increases in prescriptions over the last 20 years. The drugs are effective in treating rheumatoid arthritis, psoriasis and ...

The drug giants moved in near-perfect synchronicity, raising prices for their top-selling arthritis treatments as though they were opposite-corner gas stations bumping up the price of unleaded. The ...

An icon in the shape of a lightning bolt. Impact Link A new therapeutic treatment might be making its way to the anti-aging market, and it could stand to disrupt multibillion-dollar franchises like ...